サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1610019

乳がんブラキセラピー市場規模、シェア、動向分析レポート：技術別、製品別、地域別、セグメント予測、2025年～2030年

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
乳がんブラキセラピー市場規模、シェア、動向分析レポート：技術別、製品別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月08日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乳がんブラキセラピー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の乳がんブラキセラピー市場規模は、2025～2030年にかけてCAGR 6.9%で拡大し、2030年には13億米ドルに達すると推定されています。

乳がんの有病率の増加は市場成長を加速すると予想されています。例えば、Breastcancer.orgの報告によると、2020年1月現在、米国で乳がんに罹患している女性は350万人を超えています。

さらに、学術医療センター、腫瘍センター、病院によるブラキセラピーの採用が増加していることも、市場成長を後押しすると予想されます。例えば、2018年10月、Navicent Health社は、iCAD, Inc.が開発したXoft Axxent電子ブラキセラピー（eBx）システムをジョージア州の乳がん治療に採用しました。さらに2018年10月には、SUNY Upstate Medical Universityも早期乳がんの治療にXoft Axxent Electronic Brachytherapy（eBx）システムを採用しました。

さらに、発展途上国の政府系病院は、患者により質の高い治療を提供するために先進的なシステムを導入しています。例えば、2018年8月、Eckert and Ziegler BEBIGはネパールのBP Koirala Memorial Cancer HospitalにSagiNova HDRアフターローダーを納入・設置しました。SagiNovaは間質性乳房インプラントに適しています。したがって、病院によるこのようなブラキセラピーシステムの使用は、市場の成長を促進すると予想されます。

共同研究やパートナーシップなどの戦略的イニシアティブに参入する市場参入企業は、今後数年間の需要を促進すると予想されています。例えば、2018年7月、RaySearchは、EckertとZiegler BEBIGと提携し、SagiNovaをRayCare腫瘍学情報システムとRayStation治療計画システムと統合し、ブラキセラピー中の治療成績を改善しました。

医療センターにおけるHDRユニットに対する団体による資金提供イニシアチブの増加が市場を牽引すると推定されます。例えば、2019年4月、OSJ Charities Trust Fundは、全国イタリア系カナダ人連盟と協力し、標的を絞ったアプローチと治療時間の短縮を目的とした外照射療法の代替として、サント・スピリト病院にSagiNovaを寄贈しました。

腫瘍医、外科医、病院にとって有利な償還施策が市場成長を促進すると予想されます。例えば、HDRブラキセラピーは、メディケア・メディケイドサービスセンター（CMS）が発行したコーディングによると、5日間の治療期間に対して1万1,000米ドルがメディケア償還金として支払われます。

乳がんブラキセラピー市場レポートハイライト

  • HDRブラキセラピーは2024年に市場を席巻し、予測期間中最も急成長する技術セグメントと予測されます。
  • 放射線の迅速な照射、精度、短時間での腫瘍特異的な正確な線量照射などの要因が、このセグメントを牽引すると予測されています。
  • 北米は、主要参入企業の存在と、腫瘍センターや病院での治療採用の増加により、2024年の市場を独占しています。
  • アジア太平洋では、アンメットニーズが高く、投資家や企業がこの地域でプレゼンスを拡大する成長機会があるため、市場は予測期間中に急成長するとみられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 乳がんブラキセラピー市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 乳がんブラキセラピー市場：技術ビジネス分析

  • 技術市場シェア、2024年と2030年
  • 技術セグメントダッシュボード
  • 市場規模と予測と動向分析、技術別、2018～2030年
  • HDR（高線量率）
  • LDR（低線量率）

第5章 乳がんブラキセラピー市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • アプリケーターとアフターローダー
  • 電子ブラキセラピー
  • その他

第6章 乳がんブラキセラピー市場：技術、製品、地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Eckert &Ziegler BEBIG
    • Elekta
    • Varian Medical Systems, Inc.
    • Hologic, Inc.
    • Merit Medical Systems
    • BD
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global breast cancer brachytherapy market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 12 Canada breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Europe breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 19 UK breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Germany breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 22 France breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Italy breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Spain breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Norway breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Denmark breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Denmark breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Japan breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 39 China breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 40 China breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 41 India breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 42 India breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Australia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 46 South Korea breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Thailand breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Latin America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Brazil breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Argentina breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 64 UAE breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Kuwait breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast cancer brachytherapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology and product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Breast cancer brachytherapy market dynamics
  • Fig. 12 Breast cancer brachytherapy market: Porter's five forces analysis
  • Fig. 13 Breast cancer brachytherapy market: PESTLE analysis
  • Fig. 14 Breast cancer brachytherapy market: Technology segment dashboard
  • Fig. 15 Breast cancer brachytherapy market: Technology market share analysis, 2024 & 2030
  • Fig. 16 High dose rate (HDR) market, 2018 - 2030 (USD Million)
  • Fig. 17 Low dose rate (LDR) market, 2018 - 2030 (USD Million)
  • Fig. 18 Breast cancer brachytherapy market: Product segment dashboard
  • Fig. 19 Breast cancer brachytherapy market: Product market share analysis, 2024 & 2030
  • Fig. 20 Applicators and afterloaders market, 2018 - 2030 (USD Million)
  • Fig. 21 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Breast cancer brachytherapy market revenue, by region
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. country dynamics
  • Fig. 28 U.S. breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada country dynamics
  • Fig. 30 Canada breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico country dynamics
  • Fig. 32 Mexico breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 34 UK country dynamics
  • Fig. 35 UK breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany country dynamics
  • Fig. 37 Germany breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 38 France country dynamics
  • Fig. 39 France breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy country dynamics
  • Fig. 41 Italy breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain country dynamics
  • Fig. 43 Spain breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway country dynamics
  • Fig. 45 Norway breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden country dynamics
  • Fig. 47 Sweden breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark country dynamics
  • Fig. 49 Denmark breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan country dynamics
  • Fig. 52 Japan breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 53 China country dynamics
  • Fig. 54 China breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 55 India country dynamics
  • Fig. 56 India breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia country dynamics
  • Fig. 58 Australia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand country dynamics
  • Fig. 62 Thailand breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina country dynamics
  • Fig. 67 Argentina breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 68 MEA breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa country dynamics
  • Fig. 70 South Africa breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia country dynamics
  • Fig. 72 Saudi Arabia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE country dynamics
  • Fig. 74 UAE breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait country dynamics
  • Fig. 76 Kuwait breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategic framework
目次
Product Code: GVR-4-68038-953-1

Breast Cancer Brachytherapy Market Growth & Trends:

The global breast cancer brachytherapy market size is estimated to reach USD 1.3 billion by 2030, expanding at a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of breast cancer is expected to accelerate market growth. For instance, the Breastcancer.org reported that as of January 2020, there were more than 3.5 million women suffering from breast cancer in the U.S.

In addition, the rising adoption of brachytherapy by academic medical centers, oncology centers, and hospitals is expected to boost the market growth. For instance, in October 2018, Navicent Health adopted the Xoft Axxent Electronic Brachytherapy (eBx) System developed by iCAD, Inc. for the treatment of breast cancer in Georgia. Furthermore, in October 2018, SUNY Upstate Medical University also adopted the Xoft Axxent Electronic Brachytherapy (eBx) System to provide treatment for early-stage breast cancer.

Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2018, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.

Market players entering into strategic initiatives such as collaborations and partnerships are anticipated to propel the demand over the next few years. For instance, in July 2018, RaySearch partnered with Eckert and Ziegler BEBIG to integrate SagiNova with the RayCare oncology information system and RayStation treatment planning system to improve treatment outcomes during brachytherapy.

An increase in funding initiatives for HDR units in medical centers by organizations is estimated to drive the market. For instance, in April 2019, OSJ Charities Trust Fund collaborated with the National Federation of Italian Canadians to donate SagiNova for Santo Spirito Hospital as an alternative to external beam radiation therapy for a targeted approach and shorter treatment time.

Favorable reimbursement policies for oncologists, surgeons, and hospitals are expected to fuel market growth. For instance, HDR brachytherapy offers USD 11,000 as Medicare reimbursement for five days treatment period according to the coding issued by Centers for Medicare and Medicaid Services (CMS).

Breast Cancer Brachytherapy Market Report Highlights:

  • HDR brachytherapy dominated the market in 2024 and is also projected to be the fastest-growing technology segment over the forecast period
  • Factors such as rapid delivery of radiation, accuracy, and precise tumor-specific dose delivery in a shorter period of time are expected to drive the segment
  • North America has dominated the market in 2024 owing to the presence of key players and increasing adoption of the therapy by oncology centers and hospitals
  • In Asia Pacific, the market is estimated to grow fast over the forecast period due to high unmet needs and growth opportunities for investors and companies to expand their presence in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Breast Cancer Brachytherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Breast Cancer Brachytherapy Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. High Dose Rate (HDR)
    • 4.4.1. High Dose Rate (HDR) Market, 2018 - 2030 (USD Million)
  • 4.5. Low Dose Rate (LDR)
    • 4.5.1. Low Dose Rate (LDR) Market, 2018 - 2030 (USD Million)

Chapter 5. Breast Cancer Brachytherapy Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Applicators and Afterloaders
    • 5.4.1. Applicators and Afterloaders Market, 2018 - 2030 (USD Million)
  • 5.5. Electronic Brachytherapy
    • 5.5.1. Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Breast Cancer Brachytherapy Market: Regional Estimates & Trend Analysis by Technology and Product

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Eckert & Ziegler BEBIG
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Elekta
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Varian Medical Systems, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Hologic, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Merit Medical Systems
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. BD
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives